Docgo Inc.

Health Care
Medical/Nursing Services
www.docgo.com

Earnings Score
Moat Score
Safety Score

Market Cap $423.73M
PE 15
Debt $74.08K
Cash $108.58M
EV $315.23M
FCF $35.06M

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	$28.58M
EBIT	$48.36M
ROE	9%
ROA	10%
FCF	$35.06M
Equity	$325.21M
Growth Stability	1
PE	14.83
PEG	-0.97
PB	1.3
P/FCF	12.09
P/S	0.61
Price/Cash	0.26
Debt/Equity	0
Debt/FCF	0
Net Margins	4%
Op. Margins	7%
Earnings CAGR	-15%
Sales Growth YoY	-26%
Sales Growth QoQ	-16%
Sales CAGR	23%
Equity CAGR	198%
Earnings Stability	-0.8
Earnings Growth YoY	-5%

Earnings Growth QoQ	-22%
Earnings CAGR 5Y	-15%
Sales CAGR 5Y	23%
Equity CAGR 5Y	198%
Earnings CAGR 3Y	30%
Sales CAGR 3Y	30%
Equity CAGR 3Y	13%
Market Cap	$423.73M
Revenue	$694.97M
Assets	$493.88M
Total Debt	$74.08K
Cash	$108.58M
Shares Outstanding	101.98M
EV	315.23M
Earnings Score	6%
Moat Score	85%
Safety Score	98%
Final Score	63%
Working Capital	178.1M
Current Ratio	2.19
Shares Growth 3y	5%
Equity Growth QoQ	2%
Equity Growth YoY	12%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. DocGo is disrupting the traditional four-wall healthcare system by providing care at the scale of humanity. Its innovative technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace.

SEC Filings

Direct access to Docgo Inc. (DCGO) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2022
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31

Sector Comparison

How does Docgo Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Docgo Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR -15%

Stability -80%

loading chart...

Docgo Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Docgo Inc..

Years

Calculation mode

= $351M

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	$35M	$35M	$35M	$35M	$35M	$35M	$35M	$35M	$35M	$35M	$35M	$351M
DCF		$32M	$29M	$26M	$24M	$22M	$20M	$18M	$16M	$15M	$14M	$135M
Value	$351M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	12/2021	12/2022	12/2023	TTM
Net Margins	6%	7%	1%	4%
ROA	6%	6%	3%	10%
ROE	8%	11%	2%	9%

Bad Net Margins (4.24%)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	12/2021	12/2022	12/2023	TTM
Debt over FCF	-	-0.03	-0	0
Debt over Equity	0.01	0.01	0	0
Growth Stability	-	-	-	1

Good Debt/FCF ratio (0)

Net Margins are high enough to offer a good protection on the profits in case of higher costs or higher interests. Furthermore higher margins reduce earnings’ volatility.

Good Debt/Equity ratio (0)

The company is not overleveraged and has a good balance between equity and debt.

Good Graham’s Stability (1)

The company has a good stability in its earnings, which is a sign of a good competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	12/2021	12/2022	12/2023	CAGR 5Y
Revenue YoY growth	-	38%	42%	23%
Earnings YoY growth	-	60%	-78%	-15%
Equity YoY growth	-	23%	9%	198%
FCF YoY growth	-	218%	76%	-